Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Colorectal Neoplasms

Free Subscription Articles published in PLoS One Retrieve available abstracts of 148 articles: HTML format

Single Articles

January 2023
1. PURNOMO HD, Permatadewi CO, Prasetyo A, Indiarso D, et al
   Colorectal cancer screening in Semarang, Indonesia: A multicenter primary health care based study.
   PLoS One. 2023;18:e0279570.
   PubMed     Abstract available
   
   
   
2. BEILMANN-LEHTONEN I, Kasurinen J, Hagstrom J, Kaprio T, et al
   High tissue expression of TLRs combined with high density of tumor infiltrating lymphocytes predicts a better prognosis in colorectal cancer patients.
   PLoS One. 2023;18:e0280085.
   PubMed     Abstract available
   
   
   
3. NSO N, Nyabera A, Nassar M, Mbome Y, et al
   Incidence and risk factors of cardiovascular mortality in patients with gastrointestinal adenocarcinoma.
   PLoS One. 2023;18:e0262013.
   PubMed     Abstract available
   
   
   
4. SORENSEN AL, Guldmann-Christensen M, Borgesen M, Petersen RK, et al
   Detection of BRAF mutations in malignant melanoma and colorectal cancer by SensiScreen(R) FFPE BRAF qPCR assay.
   PLoS One. 2023;18:e0281558.
   PubMed     Abstract available
   
   
   
5. 
   Retraction: Overexpression of YAP and TAZ Is an Independent Predictor of Prognosis in Colorectal Cancer and Related to the Proliferation and Metastasis of Colon Cancer Cells.
   PLoS One. 2023;18:e0281614.
   PubMed    
   
   
   
6. CHOE L, Lau J, Yip LT, Kim G, et al
   Gastroscopy after positive screening for faecal immunochemical tests and colonoscopy: A systematic review.
   PLoS One. 2023;18:e0281557.
   PubMed     Abstract available
   
   
   
7. CHOI J, Kim N, Nam RH, Kim JW, et al
   Influence of location-dependent sex difference on PD-L1, MMR/MSI, and EGFR in colorectal carcinogenesis.
   PLoS One. 2023;18:e0282017.
   PubMed     Abstract available
   
   
   
8. GARCIA JA, Chen R, Xu M, Comerford SA, et al
   Acss2/HIF-2 signaling facilitates colon cancer growth and metastasis.
   PLoS One. 2023;18:e0282223.
   PubMed     Abstract available
   
   
   
9. VERNMARK K, Knutsen A, Loftas P, Sun XF, et al
   The impact of adjuvant chemotherapy on survival in mucinous and non-mucinous rectal adenocarcinoma patients after TME surgery.
   PLoS One. 2023;18:e0282211.
   PubMed     Abstract available
   
   
   
10. NISHIO M, Kunisaki R, Shibata W, Ajioka Y, et al
    Serrated polyps in patients with ulcerative colitis: Unique clinicopathological and biological characteristics.
    PLoS One. 2023;18:e0282204.
    PubMed     Abstract available
    
    
    
11. HU A, Roberts C, Moscalu A, Redston M, et al
    Ang1 and Ang4 differentially affect colitis and carcinogenesis in an AOM-DSS mouse model.
    PLoS One. 2023;18:e0281529.
    PubMed     Abstract available
    
    
    
12. YANG X, Cao Q, Ma B, Xia Y, et al
    Probiotic powder ameliorates colorectal cancer by regulating Bifidobacterium animalis, Clostridium cocleatum, and immune cell composition.
    PLoS One. 2023;18:e0277155.
    PubMed     Abstract available
    
    
    January 2022
13. MEIJER TS, Dieters JHN, de Leede EM, de Geus-Oei LF, et al
    Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer.
    PLoS One. 2022;17:e0261939.
    PubMed     Abstract available
    
    
    
14. SHIRAISHI T, Tominaga T, Nonaka T, Hashimoto S, et al
    Effect of hemodialysis on short-term outcomes after colon cancer surgery.
    PLoS One. 2022;17:e0262531.
    PubMed     Abstract available
    
    
    
15. 
    Expression of Concern: Tumor Associated Macrophages Protect Colon Cancer Cells from TRAIL-Induced Apoptosis through IL-1beta- Dependent Stabilization of Snail in Tumor Cells.
    PLoS One. 2022;17:e0263429.
    PubMed    
    
    
    
16. DONG XF, Wang Y, Tang CH, Huang BF, et al
    Upregulated WTAP expression in colorectal cancer correlates with tumor site and differentiation.
    PLoS One. 2022;17:e0263749.
    PubMed     Abstract available
    
    
    
17. ALAQBI SS, Burke L, Guterman I, Green C, et al
    Increased mitochondrial proline metabolism sustains proliferation and survival of colorectal cancer cells.
    PLoS One. 2022;17:e0262364.
    PubMed     Abstract available
    
    
    
18. VAN DER MEULEN MP, Toes-Zoutendijk E, Spaander MCW, Dekker E, et al
    Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing.
    PLoS One. 2022;17:e0264067.
    PubMed     Abstract available
    
    
    
19. MITSAKOS AT, Irish W, Parikh AA, Snyder RA, et al
    The association of health insurance and race with treatment and survival in patients with metastatic colorectal cancer.
    PLoS One. 2022;17:e0263818.
    PubMed     Abstract available
    
    
    
20. MUTHAMILSELVAN S, Raghavendran A, Palaniappan A
    Stage-differentiated ensemble modeling of DNA methylation landscapes uncovers salient biomarkers and prognostic signatures in colorectal cancer progression.
    PLoS One. 2022;17:e0249151.
    PubMed     Abstract available
    
    
    
21. RYE MS, Garrett KL, Holt RA, Platell CF, et al
    Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load.
    PLoS One. 2022;17:e0262416.
    PubMed     Abstract available
    
    
    
22. MIYAKAWA T, Kawamura H, Honda M, Takano Y, et al
    Impact of histological subtype on prognosis in stage IV colorectal cancer: A population-based cohort study.
    PLoS One. 2022;17:e0264652.
    PubMed     Abstract available
    
    
    
23. ILIC-ZIVOJINOVIC J, Krdzic I, Jovanovic A, Vukasinovic D, et al
    Transcultural adaptation and validation of the Serbian version of the colorectal-specific quality of life questionnaire FACT-C.
    PLoS One. 2022;17:e0263110.
    PubMed     Abstract available
    
    
    
24. DU J, Tao Q, Liu Y, Huang Z, et al
    Assessment of the targeted effect of Sijunzi decoction on the colorectal cancer microenvironment via the ESTIMATE algorithm.
    PLoS One. 2022;17:e0264720.
    PubMed     Abstract available
    
    
    
25. MEHRGOU A, Teimourian S
    Update of gene expression/methylation and MiRNA profiling in colorectal cancer; application in diagnosis, prognosis, and targeted therapy.
    PLoS One. 2022;17:e0265527.
    PubMed     Abstract available
    
    
    
26. MURAKAMI D, Matsuda K, Iwamoto H, Mitani Y, et al
    Prognostic value of CD155/TIGIT expression in patients with colorectal cancer.
    PLoS One. 2022;17:e0265908.
    PubMed     Abstract available
    
    
    
27. LEE KY, Lee J, Park YY, Oh ST, et al
    Use of gentamicin-collagen sponge (Collatamp(R) G) in minimally invasive colorectal cancer surgery: A propensity score-matched study.
    PLoS One. 2022;17:e0264513.
    PubMed     Abstract available
    
    
    
28. YANG WY, Izzi B, Bress AP, Thijs L, et al
    Association of colorectal cancer with genetic and epigenetic variation in PEAR1-A population-based cohort study.
    PLoS One. 2022;17:e0266481.
    PubMed     Abstract available
    
    
    
29. MENG F, Cao Y, Su H, Liu T, et al
    Newcastle disease virus expressing an angiogenic inhibitor exerts an enhanced therapeutic efficacy in colon cancer model.
    PLoS One. 2022;17:e0264896.
    PubMed     Abstract available
    
    
    
30. WONGKAEWKHIAW S, Wongrakpanich A, Krobthong S, Saengsawang W, et al
    Induction of apoptosis in human colorectal cancer cells by nanovesicles from fingerroot (Boesenbergia rotunda (L.) Mansf.).
    PLoS One. 2022;17:e0266044.
    PubMed     Abstract available
    
    
    
31. PELLAT A, Boutron I, Ravaud P
    Availability of results of interventional studies assessing colorectal cancer from 2013 to 2020.
    PLoS One. 2022;17:e0266496.
    PubMed     Abstract available
    
    
    
32. FILIPOWICZ N, Drezek K, Horbacz M, Wojdak A, et al
    Comprehensive cancer-oriented biobanking resource of human samples for studies of post-zygotic genetic variation involved in cancer predisposition.
    PLoS One. 2022;17:e0266111.
    PubMed     Abstract available
    
    
    
33. ROJAS ROJAS T, Poizot-Martin I, Rey D, Duvivier C, et al
    Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France.
    PLoS One. 2022;17:e0261069.
    PubMed     Abstract available
    
    
    
34. NEJADGHADERI SA, Roshani S, Mohammadi E, Yoosefi M, et al
    The global, regional, and national burden and quality of care index (QCI) of colorectal cancer; a global burden of disease systematic analysis 1990-2019.
    PLoS One. 2022;17:e0263403.
    PubMed     Abstract available
    
    
    
35. ZHANG H, Wang J, Yu T, Wang J, et al
    Silencing LncRNA CASC9 inhibits proliferation and invasion of colorectal cancer cells by MiR-542-3p/ILK.
    PLoS One. 2022;17:e0265901.
    PubMed     Abstract available
    
    
    
36. LOPEZ-JIMENEZ T, Duarte-Salles T, Plana-Ripoll O, Recalde M, et al
    Association between metabolic syndrome and 13 types of cancer in Catalonia: A matched case-control study.
    PLoS One. 2022;17:e0264634.
    PubMed     Abstract available
    
    
    
37. ISIK Z, Leblebici A, Demir Karaman E, Karaca C, et al
    In silico identification of novel biomarkers for key players in transition from normal colon tissue to adenomatous polyps.
    PLoS One. 2022;17:e0267973.
    PubMed     Abstract available
    
    
    
38. ZHANG Y, Liu X, Li A, Tang X, et al
    A pan-cancer analysis on the carcinogenic effect of human adenomatous polyposis coli.
    PLoS One. 2022;17:e0265655.
    PubMed     Abstract available
    
    
    
39. HUSSAN H, Zhao J, Badu-Tawiah AK, Stanich P, et al
    Utility of machine learning in developing a predictive model for early-age-onset colorectal neoplasia using electronic health records.
    PLoS One. 2022;17:e0265209.
    PubMed     Abstract available
    
    
    
40. KANG J, Kim H, Park H, Lee B, et al
    Risk factors and economic burden of postoperative anastomotic leakage related events in patients who underwent surgeries for colorectal cancer.
    PLoS One. 2022;17:e0267950.
    PubMed     Abstract available
    
    
    
41. GREENE MW, Abraham PT, Kuhlers PC, Lipke EA, et al
    Consensus molecular subtype differences linking colon adenocarcinoma and obesity revealed by a cohort transcriptomic analysis.
    PLoS One. 2022;17:e0268436.
    PubMed     Abstract available
    
    
    
42. KAUFMAN E, Williamson T, Mayrand MH, Burchell AN, et al
    Identifying risk factors for prevalent anal human papillomavirus type 16 infection in women living with HIV.
    PLoS One. 2022;17:e0268521.
    PubMed     Abstract available
    
    
    
43. OSHIMA K, Hirano H, Shoji H, Iwasa S, et al
    Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer.
    PLoS One. 2022;17:e0269115.
    PubMed     Abstract available
    
    
    
44. LU F, Chen S, Shi W, Su X, et al
    GPC1 promotes the growth and migration of colorectal cancer cells through regulating the TGF-beta1/SMAD2 signaling pathway.
    PLoS One. 2022;17:e0269094.
    PubMed     Abstract available
    
    
    
45. AITCHISON A, Pearson JF, Purcell RV, Frizelle FA, et al
    Detection of Fusobacterium nucleatum DNA in primary care patient stool samples does not predict progression of colorectal neoplasia.
    PLoS One. 2022;17:e0269541.
    PubMed     Abstract available
    
    
    
46. MARTINEZ-LAGO N, Cameselle Garcia S, Alonso de Castro B, Gomez-Randulfe Rodriguez MI, et al
    Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen.
    PLoS One. 2022;17:e0269399.
    PubMed     Abstract available
    
    
    
47. LARABEE SM, Cheng K, Raufman JP, Hu S, et al
    Muscarinic receptor activation in colon cancer selectively augments pro-proliferative microRNA-21, microRNA-221 and microRNA-222 expression.
    PLoS One. 2022;17:e0269618.
    PubMed     Abstract available
    
    
    
48. SOMUNCU B, Ekmekcioglu A, Antmen FM, Ertuzun T, et al
    Targeting mitochondrial DNA polymerase gamma for selective inhibition of MLH1 deficient colon cancer growth.
    PLoS One. 2022;17:e0268391.
    PubMed     Abstract available
    
    
    
49. TYAGI A, Shabbir U, Chen X, Chelliah R, et al
    Phytochemical profiling and cellular antioxidant efficacy of different rice varieties in colorectal adenocarcinoma cells exposed to oxidative stress.
    PLoS One. 2022;17:e0269403.
    PubMed     Abstract available
    
    
    
50. CUNNINGHAM P, Sumal A, Patton E, Helms H, et al
    Ojeok-san ameliorates visceral and somatic nociception in a mouse model of colitis induced colorectal cancer.
    PLoS One. 2022;17:e0270338.
    PubMed     Abstract available
    
    
    
51. HAMABE A, Ishii M, Kamoda R, Sasuga S, et al
    Artificial intelligence-based technology for semi-automated segmentation of rectal cancer using high-resolution MRI.
    PLoS One. 2022;17:e0269931.
    PubMed     Abstract available
    
    
    
52. MARBUN VMG, Erlina L, Lalisang TJM
    Genomic landscape of pathogenic mutation of APC, KRAS, TP53, PIK3CA, and MLH1 in Indonesian colorectal cancer.
    PLoS One. 2022;17:e0267090.
    PubMed     Abstract available
    
    
    
53. FUNG PLP, Lau VNM, Ng FF, Leung WW, et al
    Perioperative changes in haemoglobin and ferritin concentrations from preoperative intravenous iron isomaltoside for iron deficiency anaemia in patients with colorectal cancer: A pilot randomised controlled trial.
    PLoS One. 2022;17:e0270640.
    PubMed     Abstract available
    
    
    
54. SRIPAN P, Pongnikorn D, Chitapanarux I, Tangmunkongvorakul A, et al
    Geographical risk pattern and temporal trends in incidence of HPV-related cancers in northern Thailand: A population-based study.
    PLoS One. 2022;17:e0270670.
    PubMed     Abstract available
    
    
    
55. DE JONGE L, van de Schootbrugge-Vandermeer HJ, Breekveldt ECH, Spaander MCW, et al
    Modelling optimal use of temporarily restricted colonoscopy capacity in a FIT-based CRC screening program: Application during the COVID-19 pandemic.
    PLoS One. 2022;17:e0270223.
    PubMed     Abstract available
    
    
    
56. ZHU Y, Guo X, Zhang Q, Yang Y, et al
    Prognostic value of sarcopenia in patients with rectal cancer: A meta-analysis.
    PLoS One. 2022;17:e0270332.
    PubMed     Abstract available
    
    
    
57. CHEE CW, Zamakshshari NH, Lee VS, Abdullah I, et al
    Morindone from Morinda citrifolia as a potential antiproliferative agent against colorectal cancer cell lines.
    PLoS One. 2022;17:e0270970.
    PubMed     Abstract available
    
    
    
58. CUMMINGS A, Foster R, Calman L, Permyakova NV, et al
    Quality of life and health status in older adults (>/=65 years) up to five years following colorectal cancer treatment: Findings from the ColoREctal Wellbeing (CREW) cohort study.
    PLoS One. 2022;17:e0270033.
    PubMed     Abstract available
    
    
    
59. RIGTER LS, Snaebjornsson P, Rosenberg EH, Altena E, et al
    Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer.
    PLoS One. 2022;17:e0270591.
    PubMed     Abstract available
    
    
    
60. HANSEN TM, Nugent Z, Bernstein CN, Samadder NJ, et al
    Characteristics of colorectal cancer and use of colonoscopy before colorectal cancer diagnosis among individuals with inflammatory bowel disease: A population-based study.
    PLoS One. 2022;17:e0272158.
    PubMed     Abstract available
    
    
    
61. WANG D, Agrawal R, Zou S, Haseeb MA, et al
    Anatomic location of colorectal cancer presents a new paradigm for its prognosis in African American patients.
    PLoS One. 2022;17:e0271629.
    PubMed     Abstract available
    
    
    
62. AJAB S, Zoughbor S, Labania L, Olanda M, et al
    The role of microbiota in immunotherapy outcomes in colorectal cancer patients: A protocol for a systematic review.
    PLoS One. 2022;17:e0273314.
    PubMed     Abstract available
    
    
    
63. FEU S, Unzueta F, Ercilla A, Perez-Venteo A, et al
    RAD51 is a druggable target that sustains replication fork progression upon DNA replication stress.
    PLoS One. 2022;17:e0266645.
    PubMed     Abstract available
    
    
    
64. WU E, Ni J, Tao L, Xie T, et al
    A bidirectional Mendelian randomization study supports the causal effects of a high basal metabolic rate on colorectal cancer risk.
    PLoS One. 2022;17:e0273452.
    PubMed     Abstract available
    
    
    
65. LUND HAHEIM L, Thelle DS, Ronningen KS, Olsen I, et al
    Low level of antibodies to the oral bacterium Tannerella forsythia predicts bladder cancers and Treponema denticola predicts colon and bladder cancers: A prospective cohort study.
    PLoS One. 2022;17:e0272148.
    PubMed     Abstract available
    
    
    
66. OKAZAKI Y, Shibutani M, Nagahara H, Fukuoka T, et al
    Significance of information obtained during transanal drainage tube placement after anterior resection of colorectal cancer.
    PLoS One. 2022;17:e0271496.
    PubMed     Abstract available
    
    
    
67. OLSSON JB, Gugerel MB, Jessen SB, Jorgensen J, et al
    Colorectal cancer-associated SNP rs17042479 is involved in the regulation of NAF1 promoter activity.
    PLoS One. 2022;17:e0274033.
    PubMed     Abstract available
    
    
    
68. JANAKIRAMAN H, Becker SA, Bradshaw A, Rubinstein MP, et al
    Critical evaluation of an autologous peripheral blood mononuclear cell-based humanized cancer model.
    PLoS One. 2022;17:e0273076.
    PubMed     Abstract available
    
    
    
69. CASTELO M, Sue-Chue-Lam C, Paszat L, Kishibe T, et al
    Time to diagnosis and treatment in younger adults with colorectal cancer: A systematic review.
    PLoS One. 2022;17:e0273396.
    PubMed     Abstract available
    
    
    
70. CHEONG C, Kang J, Min BS, Kim NK, et al
    Impact of neoadjuvant treatment on rectal gastrointestinal stromal tumors.
    PLoS One. 2022;17:e0270887.
    PubMed     Abstract available
    
    
    
71. LEE C, Kim S, Woo J
    A comparative analysis of factors influencing colorectal cancer's age standardized mortality ratio among Korean women in the hot and cold spots.
    PLoS One. 2022;17:e0273995.
    PubMed     Abstract available
    
    
    
72. LEE HW, Song B, Kim K
    Colorectal cancers with a residual adenoma component: Clinicopathologic features and KRAS mutation.
    PLoS One. 2022;17:e0273723.
    PubMed     Abstract available
    
    
    
73. GOFRIT ON, Gofrit B, Roditi Y, Popovtzer A, et al
    Patterns of metastases progression- The linear parallel ratio.
    PLoS One. 2022;17:e0274942.
    PubMed     Abstract available
    
    
    
74. PELOSI AC, Fernandes AMAP, Maciel LF, Silva AAR, et al
    Liquid chromatography coupled to high-resolution mass spectrometry metabolomics: A useful tool for investigating tumor secretome based on a three-dimensional co-culture model.
    PLoS One. 2022;17:e0274623.
    PubMed     Abstract available
    
    
    
75. JEONG JH, Yun JW, Kim HY, Heo CY, et al
    Investigation of cell signalings and therapeutic targets in PTPRK-RSPO3 fusion-positive colorectal cancer.
    PLoS One. 2022;17:e0274555.
    PubMed     Abstract available
    
    
    
76. KAJIWARA SAITO M, Morishima T, Ma C, Koyama S, et al
    Diagnosis and treatment of digestive cancers during COVID-19 in Japan: A Cancer Registry-based Study on the Impact of COVID-19 on Cancer Care in Osaka (CanReCO).
    PLoS One. 2022;17:e0274918.
    PubMed     Abstract available
    
    
    
77. DAI L, Mugaanyi J, Zhang T, Tong J, et al
    A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas.
    PLoS One. 2022;17:e0274823.
    PubMed     Abstract available
    
    
    
78. WU J, Li Z, Zou J, Li L, et al
    A meta-analysis of the value of circulating tumor cells in monitoring postoperative recurrence and metastasis of colorectal cancer.
    PLoS One. 2022;17:e0274282.
    PubMed     Abstract available
    
    
    
79. NASCIMENTO AQ, Dantas DB, Melo GS, Gomes FC, et al
    Impact of sociodemographic factors and screening, diagnosis, and treatment strategies on colorectal cancer mortality in Brazil: A 20-year ecological study.
    PLoS One. 2022;17:e0274572.
    PubMed     Abstract available
    
    
    
80. DENIS V, Cassagnard N, Del Rio M, Cornillot E, et al
    Targeting the splicing isoforms of spleen tyrosine kinase affects the viability of colorectal cancer cells.
    PLoS One. 2022;17:e0274390.
    PubMed     Abstract available
    
    
    
81. 
    Correction: Immunoregulatory Mechanisms Underlying Prevention of Colitis-Associated Colorectal Cancer by Probiotic Bacteria.
    PLoS One. 2022;17:e0275512.
    PubMed     Abstract available
    
    
    
82. MESRI M, Hitchman L, Yiaesemidou M, Quyn A, et al
    Protocol: The role of defunctioning stoma prior to neoadjuvant therapy for locally advanced colonic and rectal cancer-A systematic review.
    PLoS One. 2022;17:e0275025.
    PubMed     Abstract available
    
    
    
83. WASSIE M, Beshah DT, Tiruneh YM
    Advanced stage presentation and its determinant factors among colorectal cancer patients in Amhara regional state Referral Hospitals, Northwest Ethiopia.
    PLoS One. 2022;17:e0273692.
    PubMed     Abstract available
    
    
    
84. ISHII M, Tominaga T, Nonaka T, Oyama S, et al
    Colon inflammatory index as a useful prognostic marker after R0 resection in patients with colorectal cancer liver metastasis.
    PLoS One. 2022;17:e0273167.
    PubMed     Abstract available
    
    
    
85. KO CY, Yao CC, Li YC, Lu LS, et al
    Clinical outcomes of endoscopic submucosal dissection for colorectal neoplasms: A single-center experience in Southern Taiwan.
    PLoS One. 2022;17:e0275723.
    PubMed     Abstract available
    
    
    
86. PARK JH, Kim MY, Choi IS, Kim JW, et al
    Identification of immune-related mechanisms of cetuximab induced skin toxicity in colorectal cancer patients.
    PLoS One. 2022;17:e0276497.
    PubMed     Abstract available
    
    
    
87. MOCHIZUKI K, Kudo SE, Kato K, Kudo K, et al
    Molecular and clinicopathological differences between depressed and protruded T2 colorectal cancer.
    PLoS One. 2022;17:e0273566.
    PubMed     Abstract available
    
    
    
88. PACHE B, Balaya V, Mathis J, Hubner M, et al
    Prevalence of anal dysplasia and HPV genotypes in gynecology patients: The ANGY cross-sectional prospective clinical study protocol.
    PLoS One. 2022;17:e0276438.
    PubMed     Abstract available
    
    
    
89. WU D, Xiang L, Peng L, Gu H, et al
    Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma.
    PLoS One. 2022;17:e0276430.
    PubMed     Abstract available
    
    
    
90. BRUCKNER HW, Bassali F, Dusowitz E, Gurell D, et al
    Actionable tests and treatments for patients with gastrointestinal cancers and historically short median survival times.
    PLoS One. 2022;17:e0276492.
    PubMed     Abstract available
    
    
    
91. EJAZ SA, Saeed A, Birmani PR, Katubi KM, et al
    In-silico Investigations of quinine and quinidine as potential Inhibitors of AKR1B1 and AKR1B10: Functional and structural characterization.
    PLoS One. 2022;17:e0271602.
    PubMed     Abstract available
    
    
    
92. ZHANG X, Ma S, Guo Y, Luo Y, et al
    Total neoadjuvant therapy versus standard therapy in locally advanced rectal cancer: A systematic review and meta-analysis of 15 trials.
    PLoS One. 2022;17:e0276599.
    PubMed     Abstract available
    
    
    
93. ANGER F, Lichthardt S, Haubitz I, Wagner J, et al
    Is there a weekend effect in emergency surgery for colorectal carcinoma? Analysis from the German StuDoQ registry.
    PLoS One. 2022;17:e0277050.
    PubMed     Abstract available
    
    
    
94. TARIQ H, Noreen Z, Ahmad A, Khan L, et al
    Colibactin possessing E. coli isolates in association with colorectal cancer and their genetic diversity among Pakistani population.
    PLoS One. 2022;17:e0262662.
    PubMed     Abstract available
    
    
    
95. MONDSCHEIN S, Subiabre F, Yankovic N, Estay C, et al
    Colorectal cancer trends in Chile: A Latin-American country with marked socioeconomic inequities.
    PLoS One. 2022;17:e0271929.
    PubMed     Abstract available
    
    
    
96. SUN Y, Li H, Ma Z, Wang J, et al
    Identification of immune subtypes and their prognosis and molecular implications in colorectal cancer.
    PLoS One. 2022;17:e0278114.
    PubMed     Abstract available
    
    
    
97. VANACLOCHA-ESPI M, Pinto-Carbo M, Martin-Pozuelo J, Romeo-Cervera P, et al
    Construction of an individual socioeconomic status index for analysing inequalities in colorectal cancer screening.
    PLoS One. 2022;17:e0278275.
    PubMed     Abstract available
    
    
    
98. MAHDOUANI M, Ben Ahmed S, Hmila F, Rais H, et al
    Functional characterization of MLH1 missense variants unveils mechanisms of pathogenicity and clarifies role in cancer.
    PLoS One. 2022;17:e0278283.
    PubMed     Abstract available
    
    
    
99. WANG Q, Li Z, Guo J, Li W, et al
    Effect of Chinese herbal medicine formula on progression-free survival among patients with metastatic colorectal cancer: Study protocol for a multi-center, double-blinded, randomized, placebo-controlled trial.
    PLoS One. 2022;17:e0275058.
    PubMed     Abstract available
    
    
    
100. XIA W, Gao Z, Jiang X, Jiang L, et al
     Alzheimer's risk factor FERMT2 promotes the progression of colorectal carcinoma via Wnt/beta-catenin signaling pathway and contributes to the negative correlation between Alzheimer and cancer.
     PLoS One. 2022;17:e0278774.
     PubMed     Abstract available
     
     
     
101. LAL A, Gao L, Tan E, McCaffrey N, et al
     Long-term benefits for lower socioeconomic groups by improving bowel screening participation in South Australia: A modelling study.
     PLoS One. 2022;17:e0279177.
     PubMed     Abstract available
     
     
     
102. KO YS, Choi YM, Kim M, Park Y, et al
     Improving quality control in the routine practice for histopathological interpretation of gastrointestinal endoscopic biopsies using artificial intelligence.
     PLoS One. 2022;17:e0278542.
     PubMed     Abstract available
     
     
     
103. RAMANATHAN K, Schliemann D, Binti Ibrahim Tamin NS, Mohan D, et al
     Facilitators and barriers to colorectal cancer screening using the immunochemical faecal occult blood test among an average-risk population in semi-rural Malaysia: A qualitative study.
     PLoS One. 2022;17:e0279489.
     PubMed     Abstract available
     
     
     
104. KIM KW, Kang HW, Yoo H, Jun Y, et al
     Association between severe hepatic steatosis examined by Fibroscan and the risk of high-risk colorectal neoplasia.
     PLoS One. 2022;17:e0279242.
     PubMed     Abstract available
     
     
     
105. SUMAN S, Moon BH, Datta K, Kallakury BVS, et al
     Heavy-ion radiation-induced colitis and colorectal carcinogenesis in Il10-/- mice display co-activation of beta-catenin and NF-kappaB signaling.
     PLoS One. 2022;17:e0279771.
     PubMed     Abstract available
     
     
     January 2021
106. 
     Correction: Positive impact of a faecal-based screening programme on colorectal cancer mortality risk.
     PLoS One. 2021;16:e0258077.
     PubMed     Abstract available
     
     
     
107. RODRIGUEZ-TOMAS E, Arenas M, Gomez J, Acosta J, et al
     Identification of potential metabolic biomarkers of rectal cancer and of the effect of neoadjuvant radiochemotherapy.
     PLoS One. 2021;16:e0250453.
     PubMed     Abstract available
     
     
     
108. SUN Q, Pastor L, Du J, Powell MJ, et al
     A novel xenonucleic acid-mediated molecular clamping technology for early colorectal cancer screening.
     PLoS One. 2021;16:e0244332.
     PubMed     Abstract available
     
     
     
109. O'SHEA R, Taylor N, Crook A, Jacobs C, et al
     Health system interventions to integrate genetic testing in routine oncology services: A systematic review.
     PLoS One. 2021;16:e0250379.
     PubMed     Abstract available
     
     
     
110. YAMANO T, Kubo S, Sonoda E, Kominato T, et al
     Assessment of circulating microRNA specific for patients with familial adenomatous polyposis.
     PLoS One. 2021;16:e0250072.
     PubMed     Abstract available
     
     
     
111. DUBE MANDISHORA RS, Rounge TB, Fitzpatrick M, Christiansen IK, et al
     Self-collected and clinician-collected anal swabs show modest agreement for HPV genotyping.
     PLoS One. 2021;16:e0250426.
     PubMed     Abstract available
     
     
     
112. EL BIZRI M, El Sheikh M, Lee GE, Sewitch MJ, et al
     Mobile health technologies supporting colonoscopy preparation: A systematic review and meta-analysis of randomized controlled trials.
     PLoS One. 2021;16:e0248679.
     PubMed     Abstract available
     
     
     
113. MORIMOTO M, Taniguchi K, Yamamoto O, Naka T, et al
     Preoperative white blood cell count predicts anastomotic leakage in patients with left-sided colorectal cancer.
     PLoS One. 2021;16:e0258713.
     PubMed     Abstract available
     
     
     
114. SHIRAKAMI Y, Nakanishi T, Ozawa N, Ideta T, et al
     Inhibitory effects of a selective prostaglandin E2 receptor antagonist RQ-15986 on inflammation-related colon tumorigenesis in APC-mutant rats.
     PLoS One. 2021;16:e0251942.
     PubMed     Abstract available
     
     
     
115. CHEN S, Wang Y, Wang B, Zhang L, et al
     A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer.
     PLoS One. 2021;16:e0258741.
     PubMed     Abstract available
     
     
     
116. 
     Expression of Concern: A novel potential role of pituitary gonadotropins in the pathogenesis of human colorectal cancer.
     PLoS One. 2021;16:e0259176.
     PubMed    
     
     
     
117. KOBORI T, Tameishi M, Tanaka C, Urashima Y, et al
     Subcellular distribution of ezrin/radixin/moesin and their roles in the cell surface localization and transport function of P-glycoprotein in human colon adenocarcinoma LS180 cells.
     PLoS One. 2021;16:e0250889.
     PubMed     Abstract available
     
     
     
118. BOWLER-BARNETT E, Martinez-Garcia FD, Sherwood M, Aleidan A, et al
     Proteomic characterization of GSK3beta knockout shows altered cell adhesion and metabolic pathway utilisation in colorectal cancer cells.
     PLoS One. 2021;16:e0246707.
     PubMed     Abstract available
     
     
     
119. CHEN YC, Tsai HL, Li CC, Huang CW, et al
     Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancer.
     PLoS One. 2021;16:e0259460.
     PubMed     Abstract available
     
     
     
120. TRUELSEN SLB, Mousavi N, Wei H, Harvey L, et al
     The cancer angiogenesis co-culture assay: In vitro quantification of the angiogenic potential of tumoroids.
     PLoS One. 2021;16:e0253258.
     PubMed     Abstract available
     
     
     
121. BULUT G, Guner Oytun M, Almuradova E, Harman M, et al
     Contribution of "complete response to treatment" to survival in patients with unresectable metastatic colorectal cancer: A retrospective analysis.
     PLoS One. 2021;16:e0259622.
     PubMed     Abstract available
     
     
     
122. EZENKWA US, Okolo CA, Ogun GO, Akere A, et al
     Cyclooxygenase-2 expression in colorectal carcinoma, adenomatous polyps and non-tumour bearing margins of resection tissues in a cohort of black Africans.
     PLoS One. 2021;16:e0255235.
     PubMed     Abstract available
     
     
     
123. ORABI KY, Abaza MS, Luqmani YA, Al-Attiyah R, et al
     Psiadin and plectranthone selectively inhibit colorectal carcinoma cells proliferation via modulating cyclins signaling and apoptotic pathways.
     PLoS One. 2021;16:e0252820.
     PubMed     Abstract available
     
     
     
124. TAKASU C, Yamashita S, Morine Y, Yoshikawa K, et al
     The role of the immunoescape in colorectal cancer liver metastasis.
     PLoS One. 2021;16:e0259940.
     PubMed     Abstract available
     
     
     
125. CHAIWONGKOT A, Phanuphak N, Pankam T, Bhattarakosol P, et al
     Human papillomavirus 16 L1 gene methylation as a potential biomarker for predicting anal intraepithelial neoplasia in men who have sex with men (MSM).
     PLoS One. 2021;16:e0256852.
     PubMed     Abstract available
     
     
     
126. OMIDVARI AH, Lansdorp-Vogelaar I, de Koning HJ, Meester RGS, et al
     Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration.
     PLoS One. 2021;16:e0253893.
     PubMed     Abstract available
     
     
     
127. KOO K, Ward R, Smith RL, Ruben J, et al
     Temporal determinants of tumour response to neoadjuvant rectal radiotherapy.
     PLoS One. 2021;16:e0254018.
     PubMed     Abstract available
     
     
     
128. SARGENTI A, Musmeci F, Cavallo C, Mazzeschi M, et al
     A new method for the study of biophysical and morphological parameters in 3D cell cultures: Evaluation in LoVo spheroids treated with crizotinib.
     PLoS One. 2021;16:e0252907.
     PubMed     Abstract available
     
     
     
129. SOMMARIVA S, Scussolini M, Cossu V, Marini C, et al
     The role of endoplasmic reticulum in in vivo cancer FDG kinetics.
     PLoS One. 2021;16:e0252422.
     PubMed     Abstract available
     
     
     
130. WANG T, Fei J, Nie S
     Clinicopathologic and prognostic implications of Golgi Phosphoprotein 3 in colorectal cancer: A meta-analysis.
     PLoS One. 2021;16:e0260035.
     PubMed     Abstract available
     
     
     
131. SYED SOFFIAN SS, Safian N, Nawi AM, Ahmad SB, et al
     Rate and associated factors of refusal to perform immunochemical Faecal Occult Blood Test (iFOBT) among semi-urban communities.
     PLoS One. 2021;16:e0258129.
     PubMed     Abstract available
     
     
     
132. BENEDEK Z, Surjan C, Belicza E
     Potential considerations in decision making on laparoscopic colorectal resections in Hungary based on administrative data.
     PLoS One. 2021;16:e0257811.
     PubMed     Abstract available
     
     
     
133. PARK J, Han JS, Jo HJ, Kim HY, et al
     Resting heart rate is associated with colorectal advanced adenoma.
     PLoS One. 2021;16:e0254505.
     PubMed     Abstract available
     
     
     
134. GOLDSBURY DE, Feletto E, Weber MF, Haywood P, et al
     Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia.
     PLoS One. 2021;16:e0260088.
     PubMed     Abstract available
     
     
     
135. CHENG YW, Li YC
     Factors affecting the follow-up time after a positive result in the fecal occult blood test.
     PLoS One. 2021;16:e0258130.
     PubMed     Abstract available
     
     
     
136. HEIL TC, Melis RJF, Maas HAAM, van Munster BC, et al
     Technical efficiency evaluation of colorectal cancer care for older patients in Dutch hospitals.
     PLoS One. 2021;16:e0260870.
     PubMed     Abstract available
     
     
     
137. PERNE C, Peters S, Cartolano M, Horpaopan S, et al
     Variant profiling of colorectal adenomas from three patients of two families with MSH3-related adenomatous polyposis.
     PLoS One. 2021;16:e0259185.
     PubMed     Abstract available
     
     
     
138. FIGUEIREDO JC, Passarelli MN, Wei W, Ahnen DJ, et al
     Proliferation, apoptosis and their regulatory protein expression in colorectal adenomas and serrated lesions.
     PLoS One. 2021;16:e0258878.
     PubMed     Abstract available
     
     
     
139. WALCHECK MT, Matkowskyj KA, Turco A, Blaine-Sauer S, et al
     Sex-dependent development of Kras-induced anal squamous cell carcinoma in mice.
     PLoS One. 2021;16:e0259245.
     PubMed     Abstract available
     
     
     
140. BREDNO J, Lipson J, Venn O, Aravanis AM, et al
     Clinical correlates of circulating cell-free DNA tumor fraction.
     PLoS One. 2021;16:e0256436.
     PubMed     Abstract available
     
     
     
141. MUNRO MJ, Peng L, Wickremesekera SK, Tan ST, et al
     Colon adenocarcinoma-derived cells possessing stem cell function can be modulated using renin-angiotensin system inhibitors.
     PLoS One. 2021;16:e0256280.
     PubMed     Abstract available
     
     
     
142. LI K, Fathan MI, Patel K, Zhang T, et al
     Colonoscopy polyp detection and classification: Dataset creation and comparative evaluations.
     PLoS One. 2021;16:e0255809.
     PubMed     Abstract available
     
     
     
143. POURNOOR E, Mousavian Z, Nowzari-Dalini A, Masoudi-Nejad A, et al
     A propagation-based seed-centric local community detection for multilayer environment: The case study of colon adenocarcinoma.
     PLoS One. 2021;16:e0255718.
     PubMed     Abstract available
     
     
     
144. MOHAMMED M, Mboya IB, Mwambi H, Elbashir MK, et al
     Predictors of colorectal cancer survival using cox regression and random survival forests models based on gene expression data.
     PLoS One. 2021;16:e0261625.
     PubMed     Abstract available
     
     
     
145. DAEMEN A, Udyavar AR, Sandmann T, Li C, et al
     Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B.
     PLoS One. 2021;16:e0262198.
     PubMed     Abstract available
     
     
     
146. SIEGEL EM, Ajidahun A, Berglund A, Guerrero W, et al
     Genome-wide host methylation profiling of anal and cervical carcinoma.
     PLoS One. 2021;16:e0260857.
     PubMed     Abstract available
     
     
     
147. ASTARITA JL, Keerthivasan S, Husain B, Senbabaoglu Y, et al
     The neutrophil protein CD177 is a novel PDPN receptor that regulates human cancer-associated fibroblast physiology.
     PLoS One. 2021;16:e0260800.
     PubMed     Abstract available
     
     
     
148. ELZINGA J, van der Lugt B, Belzer C, Steegenga WT, et al
     Characterization of increased mucus production of HT29-MTX-E12 cells grown under Semi-Wet interface with Mechanical Stimulation.
     PLoS One. 2021;16:e0261191.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: